---
title: "Lunai Bioworks (RENB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RENB.US.md"
symbol: "RENB.US"
name: "Lunai Bioworks"
industry: "生物技術"
---

# Lunai Bioworks (RENB.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |

## Company Profile

Lunai Bioworks Inc.是一家處于臨床前階段的生物技術公司，專注于開發用于治療癌症和艾滋病的藥物和生物產品，業務覆蓋美國和荷蘭。該公司通過兩個部門運營，分別為 RENB 和 RENC。公司正在開發一種基因改造的異體樹突狀細胞治療疫苗，包括 RENB-DC11，主要用于治療胰腺腫瘤的實體腫瘤；以及 RENB-DC20，用于治療乳腺癌。它還開發了一種人工智能平台技術，用于早期癌症檢測及其复發，採用多組學方法尋找即使在無症狀患者中也存在的個體生物標志物

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.84 | 274/604 | - | - | - |
| PB | -15.36 | 567/604 | 0.85 | 0.66 | 0.58 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/RENB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RENB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RENB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.